ASCO 2019 | Cervical cancer: does the western world have a benefit?

Gemma Kenter

Gemma Kenter, MD, PhD, of the Amsterdam Centre for Oncological Gynaecology, Amsterdam, The Netherlands, tells us about a trial she was involved with that investigated the use of neoadjuvant chemotherapy and radical surgery to standard chemotherapy and radiation for the treatment of cervical cancer. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Share this video